DK1077688T3 - Transdermalt terapeutisk syestem (TTS) indeholdende pergolid - Google Patents

Transdermalt terapeutisk syestem (TTS) indeholdende pergolid

Info

Publication number: DK1077688T3
Authority: DK; Denmark
Prior art keywords: tts; pergolide; meth; therapeutic system; transdermal therapeutic
Prior art date: 1998-05-15

Application number

DK99923585T

Other languages

Danish (da)

English (en)

Inventor

Christoph Arth

Andreas Kollmeyer-Seeger

Stephan Rimpler

Hans-Michael Wolff

Original Assignee

Sanol Arznei Schwarz Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-15

Filing date

1999-05-12

Publication date

2002-04-02

1999-05-12 Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh

2002-04-02 Application granted granted Critical

2002-04-02 Publication of DK1077688T3 publication Critical patent/DK1077688T3/da

Links

YEHCICAEULNIGD-MZMPZRCHSA-N pergolide Chemical compound C1=CC([C@H]2C[C@@H](CSC)CN([C@@H]2C2)CCC)=C3C2=CNC3=C1 YEHCICAEULNIGD-MZMPZRCHSA-N 0.000 title abstract 4
229960004851 pergolide Drugs 0.000 title abstract 4
230000001225 therapeutic effect Effects 0.000 title abstract 2
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
229920001577 copolymer Polymers 0.000 abstract 2
125000003277 amino group Chemical group 0.000 abstract 1
125000000656 azaniumyl group Chemical group [H][N+]([H])([H])[*] 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229920000058 polyacrylate Polymers 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK99923585T 1998-05-15 1999-05-12 Transdermalt terapeutisk syestem (TTS) indeholdende pergolid DK1077688T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19821788A DE19821788C1 (de)	1998-05-15	1998-05-15	Transdermales Therapeutisches System (TTS) Pergolid enthaltend
PCT/EP1999/003278 WO1999059558A1 (fr)	1998-05-15	1999-05-12	Systeme therapeutique transdermique contenant du pergolide

Publications (1)

Publication Number	Publication Date
DK1077688T3 true DK1077688T3 (da)	2002-04-02

Family

ID=7867847

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99923585T DK1077688T3 (da)	1998-05-15	1999-05-12	Transdermalt terapeutisk syestem (TTS) indeholdende pergolid

Country Status (19)

Country	Link
US (1)	US6461636B1 (fr)
EP (1)	EP1077688B1 (fr)
JP (1)	JP4556039B2 (fr)
KR (1)	KR100507266B1 (fr)
CN (1)	CN1190189C (fr)
AT (1)	ATE210432T1 (fr)
AU (1)	AU743229C (fr)
BR (1)	BR9910404B1 (fr)
CA (1)	CA2327187C (fr)
DE (2)	DE19821788C1 (fr)
DK (1)	DK1077688T3 (fr)
ES (1)	ES2167116T3 (fr)
IL (1)	IL138005A (fr)
MX (1)	MXPA00011253A (fr)
NO (1)	NO329042B1 (fr)
PL (1)	PL192213B1 (fr)
PT (1)	PT1077688E (fr)
WO (1)	WO1999059558A1 (fr)
ZA (1)	ZA200004670B (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE44145E1 (en)	2000-07-07	2013-04-09	A.V. Topchiev Institute Of Petrochemical Synthesis	Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10033855A1 (de) *	2000-07-12	2002-01-31	Hexal Ag	Matrixkontrolliertes transdermales System mit Sulfonsäuresalz eines ACE-Hemmers
DE10043321B4 (de) *	2000-08-24	2005-07-28	Neurobiotec Gmbh	Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) *	2000-10-20	2002-05-02	Schering Ag	Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10341317B4 (de) *	2003-09-03	2008-10-23	Axxonis Pharma Ag	Transdermales therapeutisches System (TTS) zur Verabreichung von Ergolinverbindungen ausgenommen Pergolid
DE10064453A1 (de) *	2000-12-16	2002-07-04	Schering Ag	Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
GB0102342D0 (en) *	2001-01-30	2001-03-14	Smithkline Beecham Plc	Pharmaceutical formulation
ES2559666T3 (es) *	2001-03-07	2016-02-15	Hisamitsu Pharmaceutical Co., Inc.	Parche adhesivo
EP1390084B1 (fr)	2001-05-01	2011-03-23	A.V. Topchiev Institute of Petrochemical Synthesis	Composition bioadhesive biphase absorbant l'eau
US8541021B2 (en)	2001-05-01	2013-09-24	A.V. Topchiev Institute Of Petrochemical Synthesis	Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8840918B2 (en)	2001-05-01	2014-09-23	A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences	Hydrogel compositions for tooth whitening
ES2331302T3 (es)	2001-05-01	2009-12-29	A.V. Topchiev Institute Of Petrochemical Synthesis	Composiciones de hidrogel.
US20050113510A1 (en)	2001-05-01	2005-05-26	Feldstein Mikhail M.	Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US20050215727A1 (en)	2001-05-01	2005-09-29	Corium	Water-absorbent adhesive compositions and associated methods of manufacture and use
US8206738B2 (en)	2001-05-01	2012-06-26	Corium International, Inc.	Hydrogel compositions with an erodible backing member
DE10234673B4 (de)	2002-07-30	2007-08-16	Schwarz Pharma Ag	Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
JP4213432B2 (ja) *	2002-08-28	2009-01-21	久光製薬株式会社	貼付剤
JP4792193B2 (ja)	2002-08-28	2011-10-12	久光製薬株式会社	貼付剤
DE10252863B4 (de)	2002-11-12	2007-04-19	Kronotec Ag	Holzfaserplatte, insbesondere Fussbodenpaneel
US7617651B2 (en)	2002-11-12	2009-11-17	Kronotec Ag	Floor panel
DE10252866B3 (de)	2002-11-12	2004-04-29	Kronotec Ag	Paneel und Verfahren zur Herstellung eines Paneels
EP1420125B1 (fr)	2002-11-15	2008-05-14	Flooring Technologies Ltd.	Ensemble consistant en deux panneaux de construction interconnectables et un insert pour verrouiller ces panneaux
DE10306118A1 (de)	2003-02-14	2004-09-09	Kronotec Ag	Bauplatte
US7678425B2 (en)	2003-03-06	2010-03-16	Flooring Technologies Ltd.	Process for finishing a wooden board and wooden board produced by the process
DE20304761U1 (de)	2003-03-24	2004-04-08	Kronotec Ag	Einrichtung zum Verbinden von Bauplatten, insbesondere Bodenpaneele
DE10362218B4 (de)	2003-09-06	2010-09-16	Kronotec Ag	Verfahren zum Versiegeln einer Bauplatte
DE20315676U1 (de)	2003-10-11	2003-12-11	Kronotec Ag	Paneel, insbesondere Bodenpaneel
TW200514582A (en) *	2003-10-31	2005-05-01	Hisamitsu Pharmaceutical Co	Transdermal preparation and method for reducing side effect in pergolide therapy
US7506481B2 (en)	2003-12-17	2009-03-24	Kronotec Ag	Building board for use in subfloors
DE102004005047B3 (de)	2004-01-30	2005-10-20	Kronotec Ag	Verfahren und Einrichtung zum Einbringen eines die Feder einer Platte bildenden Streifens
RU2380092C2 (ru)	2004-01-30	2010-01-27	Кориум Интернэшнл, Инк.	Быстро растворяющаяся пленка для доставки активного агента
JP4809062B2 (ja) *	2004-01-30	2011-11-02	久光製薬株式会社	カバー材及びカバー材付き貼付剤
DE102004011931B4 (de)	2004-03-11	2006-09-14	Kronotec Ag	Dämmstoffplatte aus einem Holzwerkstoff-Bindemittelfaser-Gemisch
US20080038328A1 (en) *	2004-05-28	2008-02-14	Naruhito Higo	Pasting Preparation
EP1791575B1 (fr)	2004-08-05	2014-10-08	Corium International, Inc.	Composition d'adhesif
AU2006209239A1 (en) *	2005-01-27	2006-08-03	A.V. Topchiev Institute Of Petrochemical Synthesis	Hydrophilic biocompatible adhesive formulations and uses
US20080138388A1 (en) *	2005-02-04	2008-06-12	Hisamitsu Pharmaceutical Co., Inc.	Transdermal Absorption Patch
DE102005042658B3 (de)	2005-09-08	2007-03-01	Kronotec Ag	Bauplatte, insbesondere Fußbodenpaneel
DE102005042657B4 (de)	2005-09-08	2010-12-30	Kronotec Ag	Bauplatte und Verfahren zur Herstellung
US7854986B2 (en)	2005-09-08	2010-12-21	Flooring Technologies Ltd.	Building board and method for production
DE102005063034B4 (de)	2005-12-29	2007-10-31	Flooring Technologies Ltd.	Paneel, insbesondere Bodenpaneel
DE102006006124A1 (de)	2006-02-10	2007-08-23	Flooring Technologies Ltd.	Einrichtung zum Verriegeln zweier Bauplatten
DE102006007976B4 (de)	2006-02-21	2007-11-08	Flooring Technologies Ltd.	Verfahren zur Veredelung einer Bauplatte
WO2010083035A2 (fr)	2009-01-14	2010-07-22	Corium International, Inc.	Administration transdermique de tamsulosine
JP6276429B2 (ja)	2014-06-18	2018-02-07	イーライリリーアンドカンパニー	ペルゴリドの経皮製剤およびその使用
WO2016038629A1 (fr)	2014-09-10	2016-03-17	Council Of Scientific & Industrial Research	Procédé à étape unique pour la préparation d'acétate de butyle
EP3395336A1 (fr)	2017-04-28	2018-10-31	Nitto Denko Corporation	Préparation d'absorption transdermique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2075517C (fr) *	1992-04-01	1997-03-11	John Wick	Piece transdermique incorporant une pellicule de polymeres incorporee a l'aide d'un agent actif
DE4310012A1 (de) *	1993-03-27	1994-09-29	Roehm Gmbh	Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
US6572879B1 (en) *	1995-06-07	2003-06-03	Alza Corporation	Formulations for transdermal delivery of pergolide
DE19626621A1 (de) *	1996-07-02	1998-01-08	Hexal Ag	Pflaster zur transdermalen Anwendung von Pergolid
CA2259353C (fr) *	1996-07-02	2006-09-05	Hexal Ag	Emplatre pour l'utilisation transdermique de pergolide
DE19728517C2 (de) *	1997-07-04	1999-11-11	Sanol Arznei Schwarz Gmbh	TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung

1998
- 1998-05-15 DE DE19821788A patent/DE19821788C1/de not_active Expired - Fee Related
1999
- 1999-05-12 ES ES99923585T patent/ES2167116T3/es not_active Expired - Lifetime
- 1999-05-12 KR KR10-2000-7011389A patent/KR100507266B1/ko not_active Expired - Fee Related
- 1999-05-12 PT PT99923585T patent/PT1077688E/pt unknown
- 1999-05-12 DE DE59900548T patent/DE59900548D1/de not_active Expired - Lifetime
- 1999-05-12 WO PCT/EP1999/003278 patent/WO1999059558A1/fr not_active Ceased
- 1999-05-12 JP JP2000549223A patent/JP4556039B2/ja not_active Expired - Fee Related
- 1999-05-12 IL IL13800599A patent/IL138005A/xx not_active IP Right Cessation
- 1999-05-12 EP EP99923585A patent/EP1077688B1/fr not_active Expired - Lifetime
- 1999-05-12 DK DK99923585T patent/DK1077688T3/da active
- 1999-05-12 CN CNB998062014A patent/CN1190189C/zh not_active Expired - Fee Related
- 1999-05-12 AT AT99923585T patent/ATE210432T1/de not_active IP Right Cessation
- 1999-05-12 MX MXPA00011253A patent/MXPA00011253A/es not_active IP Right Cessation
- 1999-05-12 PL PL344160A patent/PL192213B1/pl not_active IP Right Cessation
- 1999-05-12 AU AU40407/99A patent/AU743229C/en not_active Ceased
- 1999-05-12 US US09/673,069 patent/US6461636B1/en not_active Expired - Fee Related
- 1999-05-12 CA CA002327187A patent/CA2327187C/fr not_active Expired - Fee Related
- 1999-05-12 BR BRPI9910404-0A patent/BR9910404B1/pt not_active IP Right Cessation
2000
- 2000-09-06 ZA ZA200004670A patent/ZA200004670B/en unknown
- 2000-09-27 NO NO20004859A patent/NO329042B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
US6461636B1 (en)	2002-10-08
NO20004859D0 (no)	2000-09-27
CA2327187A1 (fr)	1999-11-25
AU743229C (en)	2003-03-20
ES2167116T3 (es)	2002-05-01
NO329042B1 (no)	2010-08-02
KR20010042685A (ko)	2001-05-25
PL344160A1 (en)	2001-10-08
PL192213B1 (pl)	2006-09-29
JP2002515424A (ja)	2002-05-28
JP4556039B2 (ja)	2010-10-06
EP1077688B1 (fr)	2001-12-12
CN1190189C (zh)	2005-02-23
AU4040799A (en)	1999-12-06
WO1999059558A1 (fr)	1999-11-25
EP1077688A1 (fr)	2001-02-28
AU743229B2 (en)	2002-01-24
ZA200004670B (en)	2000-11-22
NO20004859L (no)	2000-09-27
MXPA00011253A (es)	2003-05-19
HK1037541A1 (en)	2002-02-15
IL138005A0 (en)	2001-10-31
IL138005A (en)	2005-07-25
ATE210432T1 (de)	2001-12-15
DE19821788C1 (de)	1999-12-02
BR9910404A (pt)	2001-01-09
CA2327187C (fr)	2005-12-27
CN1301152A (zh)	2001-06-27
BR9910404B1 (pt)	2009-12-01
PT1077688E (pt)	2002-05-31
KR100507266B1 (ko)	2005-08-10
DE59900548D1 (de)	2002-01-24

Publication	Publication Date	Title
DE59900548D1 (de)	2002-01-24	Transdermales therapeutisches system (tts) pergolid enthaltend
DK1178782T3 (da)	2006-12-11	Transdermalt terapeutisk system (TTS) indeholdende tolterodin
PT92652A (pt)	1990-06-29	Processo para a preparacao de um sistema terapeutico transdermico contendo fisostigmina como ingrediente activo
SE9503924D0 (sv)	1995-11-07	Novel opioid peptides
DK0869808T3 (da)	2006-11-13	Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
DE59807891D1 (de)	2003-05-15	Transdermales therapeutisches system (tts) enthaltend ammoniogruppenhaltige (meth)acrylatpolymere zur verabreichung von levonorgestrel
DE69628163D1 (de)	2003-06-18	Nor-pregnane zur induzierung hypothalamischer effekte
UA29400C2 (uk)	2000-11-15	Пластир для трансдермального введення нітрогліцерину та спосіб його виготовлення
PT1063983E (pt)	2002-05-31	Sistema terapeutico transdermico (tts) contendo oxibutinina
DK1355636T3 (da)	2008-09-08	Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf
DK1303278T3 (da)	2009-02-09	Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
BRPI0415725A (pt)	2006-12-19	formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa
MD937C2 (ro)	1999-01-31	Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
ATE252895T1 (de)	2003-11-15	Transdermales therapeutisches system und verfahren zu seiner herstellung
KR910004603A (ko)	1991-03-29	신규 화합물
MD348C2 (ro)	1996-04-30	Sistem terapeutic transdermal şi procedeu de obţinere a acestuia
DE69803607D1 (de)	2002-03-14	Zusammensetzungen zur transdermalen und dermalen verabreichung von biologisch wirksamen stoffen
SE9502877D0 (sv)	1995-08-18	Novel opioid peptides
RU94007077A (ru)	1996-06-27	Способ производства шерсти у разводимых овец